Impact Of Physiotherapy And Botox In Improving Functional Outcomes Among Post Stroke Focal Dystonia Patients
Focal Hand Dystonia
About this trial
This is an interventional treatment trial for Focal Hand Dystonia focused on measuring Dystonia Task-specific training Botulinum toxin type A
Eligibility Criteria
Inclusion Criteria:
- Patients having first episode of unilateral stroke
- At least 6 months of post stroke duration presenting with post stroke focal dystonia of the upper limb.
- No previous exposure of the affected hand of Botox.
- Reduced upper limb functions
- Both genders will be included equally.
Exclusion Criteria:
- Significant speech or cognitive impairment which impedes the ability to perform the assessment.
- Other significant upper limb impairment e.g. fracture or frozen shoulder within 6 months.
- Severe arthritis, amputation, evidence of fixed contracture, pregnancy or lactating womens.
- Other diagnosis likely to interfere with rehabilitation or outcome assessments, e.g. blind, malignancy,
- Other conditions which may contribute to upper limb spasticity, e.g. multiple sclerosis, cerebral palsy.
- Use of botulinum toxin to the upper limb in the previous 4 months.
- Contraindications to intramuscular injection.
- Contraindications /allergy to botulinum toxin type A, which include bleeding disorders, myasthenia gravis and concurrent use of aminoglycosides.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Experimental Group
Control Group
The experimental group received botulinum toxin type A. After one week of Botox administration, a specially made task specific training program was started for these patients. It was provided for a duration of one hour and for three times per week for a total of 12 weeks by a trained physiotherapist.
The control group received only task specific training program with the same protocol as for the experimental group; for a duration of one hour and for three times per week up to a total of 12 weeks by a trained physiotherapist